Abstract:Recent advances in microfluidics-based point-of-care testing (POCT) technology such as paper, array, and beads have shown promising results for diagnosing various infectious diseases. The fast and timely detection of viral infection has proven to be a critical step for deciding the therapeutic outcome in the current COVID-19 pandemic, which in turn not only enhances the patient survival rate but also reduces the disease-associated comorbidities. In the present scenario, rapid, noninvasive detection of the virus using low cost and high throughput microfluidics-based POCT devices embraces the advantages over existing diagnostic technologies, for which a centralized lab facility, expensive instruments, sample pretreatment, and skilled personnel are required. Microfluidic-based multiplexed POCT devices can be a boon for clinical diagnosis in developing countries that lacks a centralized health care system and resources. The microfluidic devices can be used for disease diagnosis and exploited for the development and testing of drug efficacy for disease treatment in model systems. The havoc created by the second wave of COVID-19 led several countries' governments to the back front. The lack of diagnostic kits, medical devices, and human resources created a huge demand for a technology that can be remotely operated with single touch and data that can be analyzed on a phone. Recent advancements in information technology and the use of smartphones led to a paradigm shift in the development of diagnostic devices, which can be explored to deal with the current pandemic situation. This review sheds light on various approaches for the development of cost-effective microfluidics POCT devices. The successfully used microfluidic devices for COVID-19 detection under clinical settings along with their pros and cons have been discussed here. Further, the integration of microfluidic devices with smartphones and wireless network systems using the Internet-of-things will enable readers for manufacturing advanced POCT devices for remote disease management in low resource settings.

Low-Cost Optical Assays For Point-Of-Care Diagnosis In Resource-Limited Settings

Lateral And Vertical Flow Assays For Point-Of-Care Diagnostics

Point-of-Care Diagnoses and Assays Based on Lateral Flow Test

Advances in Addressing Technical Challenges of Point-of-care Diagnostics in Resource-Limited Settings

Accelerated Development of a COVID-19 Lateral Flow Test in an Academic Setting: Lessons Learned

Point-of-care diagnostics for infectious diseases: From methods to devices

Advances in Paper-Based Point-of-care Diagnostics.

Lateral flow assays: Progress and evolution of recent trends in point-of-care applications

Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges

Evaluation of the Multidimensional Enhanced Lateral Flow Immunoassay in Point-of-Care Nanosensors

Innovations in One-Step Point-of-Care Testing within Microfluidics and Lateral Flow Assays for Shaping the Future of Healthcare

Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution

The Application of Lateral Flow Immunoassay in Point of Care Testing: A Review

Plasmonic-based Platforms for Diagnosis of Infectious Diseases at the Point-of-care

Transitions in Immunoassay Leading to Next-Generation Lateral Flow Assays and Future Prospects

Progress in Point-of-Care Testing of Disease Markers Based on Microfluidic Technology

Sample preparation and detection methods in point-of-care devices towards future at-home testing

Point-of-care COVID-19 Diagnostics Powered by Lateral Flow Assay

Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis

A Portable and Universal Upconversion Nanoparticle-Based Lateral Flow Assay Platform for Point-of-care Testing.

Recent advances in point-of-care testing of COVID-19